JOSHUA P LONGINOW
Allopathic & Osteopathic Physicians|Internal Medicine CLEVELAND, OH NPI 1083175566
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine OH Abbott Laboratories All categories
General Payments — all program years on this page
$241,040.31
- Category: General Payments
- Program years: PY2023–2024
- Record count: 17
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $581.60 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $438.57 | 7 |
| Education | $143.03 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $276.58 | 4 |
| Inari Medical, Inc. | $145.45 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $120.74 | 1 |
| Kiniksa Pharmaceuticals International, plc | $25.66 | 1 |
| Janssen Pharmaceuticals, Inc | $13.17 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1078127269 | Janssen Pharmaceuticals, Inc | $13.17 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117864661 | Boehringer Ingelheim Pharmaceuticals, Inc. | $120.74 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1124830241 | Abbott Laboratories | $12.18 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1124830243 | Abbott Laboratories | $16.66 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1124830245 | Abbott Laboratories | $104.71 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1125387560 | Abbott Laboratories | $143.03 | 11/29/2024 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1140132178 | Inari Medical, Inc. | $145.45 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1154888469 | Kiniksa Pharmaceuticals International, plc | $25.66 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.